InvestorsHub Logo
Followers 5
Posts 280
Boards Moderated 0
Alias Born 08/29/2015

Re: A deleted message

Thursday, 08/08/2019 7:25:25 PM

Thursday, August 08, 2019 7:25:25 PM

Post# of 459524
You know Mav, we would like to thank you for posting about SRPT; and that they think they have an answer to Rett syndrome. A quick look into their solution, cost 1m per treatment, skips the exon51 gene, doesn't show any statistical significance makes me want to sit down and buy some. Or I can buy something that actually works, Blarcamesine, safe and effect showing multiple effects, on heart rate, breathing, seizures (in Rett). The Clinical findings that SRPT provided needed a push from the patient community because the therapy really doesn't work. Sorry to shoot down their dream, but Anavex has the best solution.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News